SMTL ID : 6lju.1

Crystal structure of human FABP4 in complex with a novel inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x EHU: 2-[[3-chloranyl-4-(methylamino)-2-phenyl-phenyl]amino]benzoic acid(Non-covalent)

EHU.1: 16 residues within 4Å: Chain A: F.37, V.44, V.46, A.54, P.59, S.76, F.78, A.96, D.97, R.99, I.125, R.127, V.136, R.147, Y.149 Ligands: EDO.2 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:F.37, A:A.54, A:P.59, A:A.96, A:I.125, A:I.125, A:V.136 Hydrogen bonds: A:D.97, A:R.99, A:Y.149 Salt bridges: A:R.147 pi-Stacking: A:F.37, A:F.78

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 6 residues within 4Å: Chain A: I.72, T.81, E.82, I.83, R.127 Ligands: EHU.1 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:T.81, A:R.127 Water bridges: A:T.81, A:T.81, A:E.93

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Su, H. et al., Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation. J.Med.Chem. (2020)

Release Date

2020-04-15

Peptides

Fatty acid-binding protein, adipocyte: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fatty acid-binding protein, adipocyte

Related Entries With Identical Sequence